- Home
- ANIP vs QNST Comparison
ANIP vs QNST Comparison
Compare ANIP & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- QNST
- Stock Information
- Founded
- ANIP 2001
- QNST 1999
- Country
- ANIP United States
- QNST United States
- Employees
- ANIP N/A
- QNST N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- QNST Business Services
- Sector
- ANIP Health Care
- QNST Consumer Discretionary
- Exchange
- ANIP Nasdaq
- QNST Nasdaq
- Market Cap
- ANIP 1.2B
- QNST 1.3B
- IPO Year
- ANIP N/A
- QNST 2010
- Fundamental
- Price
- ANIP $57.94
- QNST $20.11
- Analyst Decision
- ANIP Buy
- QNST Strong Buy
- Analyst Count
- ANIP 7
- QNST 7
- Target Price
- ANIP $77.33
- QNST $28.86
- AVG Volume (30 Days)
- ANIP 172.8K
- QNST 672.2K
- Earning Date
- ANIP 02-28-2025
- QNST 02-06-2025
- Dividend Yield
- ANIP N/A
- QNST N/A
- EPS Growth
- ANIP N/A
- QNST N/A
- EPS
- ANIP N/A
- QNST N/A
- Revenue
- ANIP $555,456,000.00
- QNST $928,723,000.00
- Revenue This Year
- ANIP $25.54
- QNST $66.42
- Revenue Next Year
- ANIP $20.95
- QNST $9.01
- P/E Ratio
- ANIP N/A
- QNST N/A
- Revenue Growth
- ANIP 23.60
- QNST 68.99
- 52 Week Low
- ANIP $52.50
- QNST $14.14
- 52 Week High
- ANIP $70.81
- QNST $26.27
- Technical
- Relative Strength Index (RSI)
- ANIP 46.25
- QNST 31.71
- Support Level
- ANIP $58.37
- QNST $22.40
- Resistance Level
- ANIP $60.54
- QNST $23.24
- Average True Range (ATR)
- ANIP 1.69
- QNST 1.26
- MACD
- ANIP -0.21
- QNST -0.41
- Stochastic Oscillator
- ANIP 20.28
- QNST 0.92
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.